Stories about research and scientific development at Mount Sinai
A Leader in Imaging, With a Like-Minded Team, Scans Mummies Around the World for Clues to Heart Disease
At the intersection of medicine, archaeology, and the plot of an Indiana Jones movie lies a course of study pursued by Jagat Narula, MD, PhD, MACC. Dr. Narula’s highly eminent day jobs include serving as the Chief of Cardiology at Mount Sinai St. Luke’s and Mount...
An Effort to Improve Clinical Trial Enrollment
Clinical researchers in the Division of Nephrology and The Charles Bronfman Institute for Personalized Medicine are leading a new initiative within the Mount Sinai Health System to dramatically accelerate the prescreening process to identify eligible candidates...
Study Shows Motivation to Bully is Regulated by Brain Reward Circuits
A team of researchers at the Icahn School of Medicine at Mount Sinai has conducted a pioneering study of mice behavior and the structure of the brain demonstrating that in some cases, aggressive social interaction— bullying—activates a primary brain reward circuit...
New Report From Mount Sinai and the United Nations Outlines Ways to Improve U.S. Health Outcomes
The United States spends more money on health care than any other country, yet has poorer outcomes with shorter average life expectancies (78.8 years, per capita) than peer nations, such as Japan and Spain, with 83.4 years and 83.2 years, respectively. Furthermore, a...
A Landmark Study Examines How Childhood Experiences Affect Adolescent Brain Development
The Icahn School of Medicine at Mount Sinai will receive $4.7 million from the National Institutes of Health (NIH) to participate in a landmark study with 20 other research centers that will examine how childhood experiences and habits affect brain development and,...
Two Researchers at Mount Sinai Have Key Roles In Breakthrough Therapy for Multiple Sclerosis
Three multicenter Phase III trials in which Mount Sinai researchers played key roles have reported highly encouraging results for the investigational drug ocrelizumab in treating both primary progressive multiple sclerosis (MS), the most disabling form of the disease,...
Mount Sinai Researcher Featured on Fox 5 News Discussing Clinical Trial for Eczema
Emma Guttman-Yassky, MD, PhD, Professor of Dermatology and Vice Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, is involved in a clinical trial for a potential new treatment for atopic dermatitis.
Mount Sinai Researcher Featured on CBS News: New drug gives hope for those with progressive multiple sclerosis
As many as 400,000 Americans are believed to suffer from multiple sclerosis -- a debilitating disease of the central nervous system. A new drug may provide relief from the most devastating form of MS. Fred Lublin, MD, director of the Corinne Goldsmith Dickinson Center...
Mount Sinai Research News: Researchers Reveal How Cancer Can Spread Even Before a Tumor Develops
Even before tumors develop, breast cancer cells with a few defined molecular alterations can spread to organs, remain quiet for long periods of time, and then awaken to form aggressive, deadly breast cancer metastasis, says a team of investigators led by researchers...